Biosimilars 2007
September 24-25, 2007
George Washington University - Jack Morton Auditorium - Washington, DC

Index

• Organizing Committee
• Sponsors
• Conference Registration Brochure
• Preliminary Program Schedule
• Who Should Attend
• Hotel Information

Adobe Acrobat software is required to view and print some of the documents
listed above. If you do not have this software, you can download it for free by
clicking on the Adobe Acrobat Reader button below.

Introduction

Biosimilars 2007 is a two day conference to "air the issues" and "raise the questions" associated with the legislation for, and applications and use of, biotech medicines currently under consideration in the United States Congress to provide the authority to the FDA to regulate Biosimilars (also called follow-on biologics or generic biologicals).

2007 is the 25th anniversary of the first genetically engineered drug approved by the FDA - Lilly's recombinant insulin - Humulin. The global development of biosimilars is now recognized to be a critical part of the future of biotechnology, as the pharma, legal and payor/patient communities consider the legal, scientific, technical, financial and economic impacts.

Participants will hear from, and interact with, leading professionals from government, non-govermental organizations and the private sector over the two-day Biosimilars2007 Conference.